Literature DB >> 309446

A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties.

I R Flockhart, P W Sheldon, I J Stratford, M E Watts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 309446     DOI： 10.1080/09553007814550661

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN： 0020-7616


× No keyword cloud information.
  5 in total

1.  Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S.

Authors:  E O Pettersen; T Lindmo
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

2.  A drug for improved radiosensitization in radiotherapy.

Authors:  S Dische; J F Fowler; M I Saunders; M R Stratford; P Anderson; A I Minchinton; M E Lee
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640

3.  Enhancement of the effect of cytotoxic drugs by radiosensitizers.

Authors:  W M Martin; N J McNally; J De Ronde
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

4.  Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.

Authors:  J M Brown; N Y Yu; P Workman
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

5.  Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.

Authors:  R A White; P Workman
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.